Use access key #2 to skip to page content.
$61.00 -0.15 (-0.25%)
7/8/2008 4:00 PM

Abraxis BioScience, Inc. (ABII)

CAPS Rating:
*****

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ABII

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

35 Outperforms
4 Underperforms
 

All-Stars

9 Outperforms
0 Underperforms
 

Players bullish on ABII are also bullish on:

Players bearish on ABII are also bearish on:

Ticker Tags

Small Cap (1922)
Suggest a tag

Abraxis BioScience, Inc. At A Glance

Current Price: $61.00
Last Trade Time: 7/8/2008 4:00 PM
Open: $59.97
Previous Close: $61.15
Daily Range: $59.03 - $61.15
52-Week Range: $1.23 - $73.44
Volume: 40,530
Market Cap: $2.45B
P/E Ratio: 179.03
Compare Our Special Broker Offers!

Stock Trends

ABII VS S&P 500 (SPY)

ABII 12 month chart vs. S&P

News & Discussion Boards

Sorry no news articles available for ABII.

Top Bull Pitch

Recs

1

Abraxis BioScience, Inc. (ABII)

Avatar TMFBiologyFool (97.70) Submitted: 3/27/08 1:11 AM

One drug on the market with a nice platform to build similar drugs. The spin off (and ticker change) has made this an unknown company which could cause its stock price to falter a little. Still there's points to be made in unknown companies.

Holding the actual dollars away from this one u...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Players

picks per page. CHANGE

Results 1 - 4 of 4  

Recs

0

 (ABII)

Avatar pjani06 (87.93) Submitted: 6/09/08 4:39 AM : Outperform Start Price: $66.51 ABII Score: -1.09

High insider ownership in high growth industry with valuations of price over sales below industry average a la yahoo finance

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABII)

Avatar anmw (< 20) Submitted: 6/08/08 1:29 PM : Underperform Start Price: $66.51 ABII Score: 1.09

If a history is any indication, then consider the PFE. A few year ago, it was trading at 150 times 12 month trail earning or about $150.00 per share. Within two-three week after achieving 150 times, it dived to $100 per share. Rest is his a history.





Newness doesn't justify 179 times. It seens a but scart to me. This is my way of kicking some tires.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABII)

Avatar fasial (< 20) Submitted: 5/09/08 1:18 PM : Underperform Start Price: $61.89 ABII Score: -6.81

i may trust here

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (ABII)

Avatar TMFBiologyFool (97.70) Submitted: 3/27/08 1:11 AM : Outperform Start Price: $60.25 ABII Score: 6.46

One drug on the market with a nice platform to build similar drugs. The spin off (and ticker change) has made this an unknown company which could cause its stock price to falter a little. Still there's points to be made in unknown companies.

Holding the actual dollars away from this one until it gets regular with its earnings announcements. We're less than a week away from the end of the 1st quarter and there's no sign of 4th quarter financial info. The spin off is holding things up, but I figure it makes since to invest in companies based on current information.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 4 of 4  

Wall Street

There are no Wall Street player picks.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners